Among diarrheagenic
Escherichia coli, those producing Shiga toxin (synonym: Vero toxin), are the most virulent to date. These Shiga toxin-producing
E. coli (STEC) can cause hemorrhagic colitis that may manifest as painful, grossly bloody diarrhea [
1] as well as hemolytic uremic syndrome (HUS) - a potentially fatal thrombotic microangiopathy, typically affecting children (pathogenesis and treatment strategies are fully discussed in the accompanying commentary by Goldwater
et al. [
2]). The case-fatality ratio of STEC illness is dependent on the patients' age and the virulence profile of the infecting strain. It is less than 1% for STEC gastroenteritis [
3]. For apparently sporadic STEC-associated HUS, the case-fatality ratio in the acute phase is between 2% and 5% [
3,
4], but it can be as high as 10% in outbreaks of the rare sorbitol-fermenting O157:H- STEC [
5].
Since their first description in 1977 [
6], many (> 100) different STEC serotypes, a categorization based on O (somatic) and H (flagellar) antigens, have been associated with human disease. Of those, O157:H7 has the strongest association with HUS worldwide [
7]. This serotype is the primary target for diagnosing human STEC infection in many countries due to its virulence and propensity to cause common source outbreaks coupled with its ease of diagnosis by culture isolation. In many countries, infection with STEC O157, regardless of the H-antigen, is probably less frequent than infection with STEC of other serogroups. These 'non-O157 STEC' constitute a heterogeneous group of organisms, which have, on the whole, a lesser risk of causing bloody diarrhea [
8,
9] and HUS [
9]. For example, prior to the large STEC O104:H4 outbreak in 2011 (see below), non-O157 STEC accounted for more than 80% of reported STEC infection, but only for approximately 1/3 of STEC-associated HUS in Germany [
4,
10].
Stools submitted for diagnosis of acute community-acquired diarrhea, even when bloody, are not always investigated for the presence of STEC. Furthermore, diagnosis of non-O157 STEC is complex and currently requires a sequential approach [
11,
12] that entails screening for Shiga toxin or its encoding genes by non-cultural methods, followed by culture, colony identification and serotyping of the respective strain. Unfortunately, some countries lack recommendations for detecting non-O157 STEC and, even in those that have them, screening for Shiga toxin (genes) appears underutilized [
12,
13]. Adding further to the problem, culture isolation and serotyping of non-O157 STEC is performed only in a few specialized laboratories. Consequently, diagnosis of STEC including serotype - the basic microbiological information needed for surveillance - occurs infrequently and is time-consuming. This delays or even prevents pathogen-specific outbreak detection. Herein lies a particular problem: pathogenic
E. coli continue to evolve [
14,
15] through inter-bacterial transfer of genetic elements, for example, via bacteriophages, transposons and plasmids, and new and emerging STEC clones will likely belong to the group of (underdiagnosed) non-O157 STEC.
The main reservoir for STEC is ruminants, particularly cattle, and most large STEC outbreaks, irrespective of serotype, have been caused by contaminated food (including drinking water) [
16-
18]. Timeliness of public health surveillance is the key to implementing effective control measures. In foodborne outbreaks, this translates into the necessity for 1) early detection, 2) timely identification of the suspected food vehicle and 3) removing it from the market, accompanied by targeted consumer advice. Minimizing secondary spread is an additional public health task to halt the outbreak, as affected persons themselves then have become a potential source of infection to others [
19].